Onartuzumab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | scatter factor receptor kinase |
Clinical data | |
Identifiers | |
1133766-06-9 | |
None | |
UNII | MS1J9720WC |
Chemical data | |
Formula | C4422H6820N1168O1363S31 |
99.1 kDa | |
(what is this?) (verify) |
Onartuzumab is a humanized monoclonal antibody designed for the treatment of cancer.[1]
Onartuzumab was developed by Genentech, Inc.
References
- ↑ "Statement On A Nonproprietary Name Adopted By The USAN Council: Onartuzumab" (PDF). American Medical Association.